Background and aim: Biliary atresia (BA) is an intractable neonatal liver disease
characterized by progressive fibrosclerotic obliteration of the extrahepatic biliary tree. The …

Background Biliary atresia (BA) is a neonatal liver disorder characterized by chronic
inflammation and obliteration of extrahepatic bile ducts. The purpose of the study was to …

Aim Biliary atresia (BA) is a neonatal liver disease defined as chronic progressive fibrotic
obliteration of extrahepatic bile ducts. The objective of this study was to determine the …

Objective Liver transient elastography (TE) using FibroScan® has gained popularity as a
non-invasive technique to assess hepatic fibrosis by measuring liver stiffness. This study …

Biliary atresia (BA) is a congenital disease characterized by obliteration of the extrahepatic
bile duct and periductal inflammation and progressive destruction of the intrahepatic bile …

To investigate the utility of liver stiffness measurement by shear wave elastography (SWE)
and several commonly used biomarkers in differentiating biliary atresia (BA) from other …

Background Validated non-invasive examinations are necessary to monitor liver fibrosis in
children with biliary atresia (BA) after the Kasai procedure. Purpose To evaluate the …

Biliary atresia (BA) is a challenging liver disease in infancy. Early diagnosis of BA is
important for timely hepatoportoenterostomy. We evaluated the age‐specific diagnostic …

Background Biliary atresia (BA) is a paediatric cholestatic disease characterized by a
progressive fibro‐inflammation of the biliary tree. Current treatment of choice is to establish …

We investigated the utility of transient elastography (TE) for diagnosing biliary atresia (BA) in
cholestatic infants and predicting the outcome of BA. Forty‐eight cholestatic infants (9‐87 …